Engineered human tumor xenografts with functional human vascular networks

Microvascular Research

Volumn 81, Issue 1, 2011, Pages 18-25

  Alonso Camino, Vanesa ^a   Santos Valle, Patricia ^a   Ispizua, Maria Carmen ^a   Sanz, Laura ^a   Álvarez Vallina, Luís ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Angiogenesis; Engineered vessels; Molecular imaging; Mouse model; Tumor

Indexed keywords

CD34 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; WHOLE BODY RADIATION;

ANIMALS; ANTIGENS, CD34; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRACKING; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; LAMININ; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, NUDE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; TISSUE ENGINEERING; TRANSPLANTATION, HETEROLOGOUS; WHOLE-BODY IRRADIATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS;

EID: 78650797767     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.10.002     Document Type: Article

References (32)

1. Ahn G., Brown J. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 2008, 13(3):193-205.
2. Alajati A., et al. Spheroid-based engineering of a human vasculature in mice. Nat. Methods 2008, 5(5):439-445.
3. Au P., et al. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008, 111(9):4551-4558.
4. Budach W., et al. Impact of stromal sensitivity on radiation response of tumors. J. Nat. Cancer Inst. 1993, 85(12):988-993.
5. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438(7070):932-936.
6. Charrier S., et al. Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells. Blood 2004, 104(4):978-985.
7. Compte M., et al. Inhibition of tumor growth in vivo by in situ secretion of bispecific anti-CEA×anti-CD3 diabodies from lentivirally transduced human lymphocytes. Cancer Gene Ther. 2007, 14(4):380-388.
8. Dimitrievich G., et al. Radiosensitivity of vascular tissue. I. Differential radiosensitivity of capillaries: a quantitative in vivo study. Radiat. Res. 1984, 99(3):511-535.
9. Dong Z., et al. Quantification of human angiogenesis in immunodeficient mice using a photon counting-based method. Biotechniques 2007, 43(1):73-77.
10. Enis D., et al. Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells. Proc. Nat. Acad. Sci. U.S.A. 2005, 102(2):425-430.
11. Ferrara N., Kerbel R. Angiogenesis as a therapeutic target. Nature 2005, 438(7070):967-974.
12. Ferrara N., et al. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discovery 2004, 3:391-400.
13. Gimbrone M.A., et al. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 1972, 136(2):261-276.
14. Gray D., et al. Short-term human prostate primary xenografts: an in vivo model of human prostate cancer vasculature and angiogenesis. Cancer Res. 2004, 64(5):1712-1721.
15. Jain R. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat. Med. 2001, 7(9):987-989.
16. Koike N., et al. Tissue engineering: creation of long-lasting blood vessels. Nature 2004, 428(6979):138-139.
17. Melero-Martin J., et al. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 2007, 109(11):4761-4768.
18. Melero-Martin J., et al. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ. Res. 2008, 103(2):194-202.
19. Milas L., et al. Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: dependency on tumor type. Cancer Res. 1986, 46(2):723-727.
20. Morton C., Houghton P. Establishment of human tumor xenografts in immunodeficient mice. Nat. Protoc. 2007, 2(2):247-250.
21. Nör J., et al. Up-regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res. 2001, 61(5):2183-2188.
22. Nör J., et al. Engineering and characterization of functional human microvessels in immunodeficient mice. Lab. Invest. 2001, 81(4):453-463.
23. Norrby K. In vivo models of angiogenesis. J. Cell Mol. Med. 2006, 10(3):588-612.
24. Rofstad E., et al. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. Cancer Res. 2005, 65(6):2387-2396.
25. Sanz L., Alvarez-Vallina L. The extracellular matrix: a new turn-of-the-screw for anti-angiogenic strategies. Trends Mol. Med. 2003, 9(6):256-262.
26. Sanz L., et al. Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels. Microvasc. Res. 2008, 75(3):308-314.
27. Sanz L., et al. Differential transplantability of human endothelial cells in colorectal cancer and renal cell carcinoma primary xenografts. Lab. Invest. 2009, 89(1):91-97.
28. Shinohara E., et al. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs. Cancer Res. 2005, 65(12):4987-4992.
29. Sholley M., et al. Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. Lab. Invest. 1984, 51(6):624-634.
30. Skovseth D., et al. Vascular morphogenesis and differentiation after adoptive transfer of human endothelial cells to immunodeficient mice. Am. J. Pathol. 2002, 160(5):1629-1637.
31. Udagawa T., et al. Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution. Cancer Res. 2007, 67(5):2040-2045.
32. Vermeulen P.B., et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur. J. Cancer 2002, 38:1564-1579.